Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/MERCK-CO-INC-13611/news/Merck-Receives-Priority-Review-from-FDA-for-Second-Application-for-KEYTRUDA-pembrolizumab-Base-30376505/?utm_source=whatsapp&utm_medium=social&utm_campaign=share